Enjeti AK - Search Results

1

Detection and measurement of microparticles: an evolving research tool for vascular biology.

Enjeti AK, Lincz LF, Seldon M. Enjeti AK, et al. Semin Thromb Hemost. 2007 Nov;33(8):771-9. doi: 10.1055/s-2007-1000369. Semin Thromb Hemost. 2007. PMID: 18175282 Review.

2

Bilateral breast lumps in a patient after sex mismatched allogeneic transplantation for aplastic anaemia.

Enjeti AK, Seldon M, Braye S. Enjeti AK, et al. J Clin Pathol. 2005 Jun;58(6):670-1. J Clin Pathol. 2005. PMID: 15917426 Free PMC article. No abstract available.

3

Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.

Enjeti AK, Walsh M, Seldon M. Enjeti AK, et al. Haemophilia. 2005 Sep;11(5):535-8. doi: 10.1111/j.1365-2516.2005.01125.x. Haemophilia. 2005. PMID: 16128899

4

Bio-maleimide as a generic stain for detection and quantitation of microparticles.

Enjeti AK, Lincz L, Seldon M. Enjeti AK, et al. Int J Lab Hematol. 2008 Jun;30(3):196-9. doi: 10.1111/j.1751-553X.2007.00937.x. Int J Lab Hematol. 2008. PMID: 18479297

5

Microparticles in health and disease.

Enjeti AK, Lincz LF, Seldon M. Enjeti AK, et al. Semin Thromb Hemost. 2008 Oct;34(7):683-91. doi: 10.1055/s-0028-1104547. Epub 2008 Dec 15. Semin Thromb Hemost. 2008. PMID: 19085769

6

Circulating microparticles are elevated in carriers of factor V Leiden.

Enjeti AK, Lincz LF, Scorgie FE, Seldon M. Enjeti AK, et al. Thromb Res. 2010 Sep;126(3):250-3. doi: 10.1016/j.thromres.2009.11.019. Epub 2009 Dec 21. Thromb Res. 2010. PMID: 20022357

7

The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles.

Alkhatatbeh MJ, Mhaidat NM, Enjeti AK, Lincz LF, Thorne RF. Alkhatatbeh MJ, et al. Among authors: enjeti ak. J Thromb Haemost. 2011 Apr;9(4):844-51. doi: 10.1111/j.1538-7836.2011.04220.x. J Thromb Haemost. 2011. PMID: 21276198 Free article.

8

Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden.

Lincz LF, Scorgie FE, Enjeti A, Seldon M. Lincz LF, et al. Thromb Res. 2012 Feb;129(2):192-6. doi: 10.1016/j.thromres.2011.06.018. Epub 2011 Jul 27. Thromb Res. 2012. PMID: 21798575

9

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.

10

The origin of circulating CD36 in type 2 diabetes.

Alkhatatbeh MJ, Enjeti AK, Acharya S, Thorne RF, Lincz LF. Alkhatatbeh MJ, et al. Among authors: enjeti ak. Nutr Diabetes. 2013 Feb 4;3(2):e59. doi: 10.1038/nutd.2013.1. Nutr Diabetes. 2013. PMID: 23381664 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters